Best in 7 days Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology US$ 20.69 Sold : Login>>
GHK-Cu Peptide Therapy: The Definitive Clinical Guide to Gene Modulation, Protocols, and Efficacy US$ 28.65 Min. order: 1 piece ★★★★★ 4.1 (285 reviews) Sold : Login>>
GHK-CU 50mg Vial | Copper Peptide US$ 28.52 Min. order: 1 piece ★★★★★ 4.4 (124 reviews) Sold : Login>>